Sign Up to like & get
recommendations!
0
Published in 2021 at "Molecular pharmaceutics"
DOI: 10.1021/acs.molpharmaceut.0c00995
Abstract: Novel peptidic glucagon receptor (GCGR) and glucagon-like peptide 1 receptor (GLP-1R) dual agonists are reported to have increased efficacy over GLP-1R monoagonists for the treatment of diabetes and obesity. We identified a novel Xenopus GLP-1-based…
read more here.
Keywords:
xenopus glp;
glp based;
glp;
glucagon receptor ... See more keywords